21118 ⎘
Medicinal preparations containing antigens or antibodies; Viral antigens; Paramyxoviridae, e.g. parainfluenza virus Newcastle disease virus
Newcastle Disease Virus with Improved Heat Resistance, and Newcastle Disease Virus Vaccine Comprising Same
#2BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS
#3Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens
#4VACCINE AGAINST INFECTIOUS BRONCHITIS
#5MULTIVALENT KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS-LIKE PARTICLES AND USES THEREOF
#6NEWCASTLE DISEASE VIRUSES AND USES THEREOF
#7HVT AIV VECTORS AND USES THEREOF
#8PRODUCTION OF VIRUSES IN CELL CULTURE
#9OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS
#10RECOMBINANT HERPESVIRUS OF TURKEY VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
#11RECOMBINANT HVT VECTORS EXPRESSING INFLUENZA HEMAGGLUTININ AND IMMUNOGENIC COMPOSITIONS, AND PRODUCTION AND USES THEREOF
#12CHIMERIC NEWCASTLE DISEASE VIRUS EXPRESSING APMV HN AND F PROTEINS
#13EXTENDED-RANGE SPRAY APPLICATOR
#14BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS
#15MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES
#16METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)
#17REDUCED FOAMING VACCINE COMPOSITIONS
#18VACCINATION FOR PROTECTING POULTRY AGAINST A POULTRY PATHOGEN
#19USING FUNGAL CONSTRUCTS TO PRODUCE VIRAL PROTEIN ANTIGENS
#20RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF
#21VACCINE ADJUVANT COMPRISING AN INVERSE MICROLATEX
#22MULTIVALENT HVT VECTOR VACCINE
#23Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#24ENGINEERED NEWCASTLE DISEASE VIRUS VECTOR AND USES THEREOF
#25Vaccine delivery method
#26tFIBER PROTEIN FRAGMENT OF AVIAN EGG DROP SYNDROME VIRUS AND VACCINE COMPOSITION PREPARED THEREOF, PREPARATION METHOD AND USE
#27REDUCED FOAMING VACCINE COMPOSITIONS
#28Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)
#29Vaccine against infectious bronchitis
#30Multivalent Kaposi sarcoma-associated herpesvirus-like particles and uses thereof
#31Production of viruses in cell culture
#32RECOMBINANT GALLID HERPESVIRUS 3 VACCINES ENCODING HETEROLOGOUS AVIAN PATHOGEN ANTIGENS
#33Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigens
#34Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof
#35Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#36BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS
#37RECOMBINANT RSV LIVE VACCINE STRAIN AND PRODUCTION METHOD THEREFOR
#38Method for rescuing and producing a virus in avian cells
#39USE OF BETA-GLUCAN EXTRACT IN IMMUNOPOTENTIATION OF AN AVIAN ANIMAL
#40Extended-range spray applicator
#41Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#42METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)
#43Vaccines with enhanced immunogenicity, low allergenicity and reactogenicity
#44Vaccine delivery method
#45EXTENDED-RANGE SPRAY APPLICATOR
#46Recombinant non-pathogenic Marek's Disease virus constructs encoding multiple heterologous antigens
#47REDUCED FOAMING VACCINE COMPOSITIONS
#48RECOMBINANT GALLID HERPESVIRUS 3 VACCINES ENCODING HETEROLOGOUS AVIAN PATHOGEN ANTIGENS
#49Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#50Newcastle disease viruses and uses thereof
#51Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)
#52INFECTIOUS BRONCHITIS VIRUS VACCINE USING NEWCASTLE DISEASE VIRAL VECTOR
#53Production of viruses in cell culture
#54RECOMBINANT CHICKEN INTERLEUKIN-1 BETA PROTEIN FOR PRODUCING ANTIBODY EARLY AND RETAINING FOR A LONGER PERIOD OF TIME AND APPLICATION THEREOF
#55Method and system for integration among content publication, advertisement services, and rewards collection
#56Vaccine against infectious bronchitis
#57Methods of making solid vaccine compositions having reduced foaming
#58Recombinant Newcastle Disease Virus Expressing an Immunomodulatory Protein as a Molecular Adiuvant
#59Reduced foaming vaccine compositions
#60Vaccine composition and preparation method and use thereof
#61Production of viruses in cell culture
#62Chimeric antigen receptor-modified immune effector cell carrying PD-L1 blocking agent
#63Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#64Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#65Altered avian virus for in-ovo inoculation and methods of use thereof
#66Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#67Vaccine composition and preparation method and use thereof
#68Method of Vaccination Comprising a Histone Deacetylase Inhibitor
#69Recombinant MDV1 and the uses thereof
#70Influenza H5 vaccines
#71HVT-vectored ND-IBD vaccine
#72Oral administration of at least one pharmaceutical and/or antigenic active substance
#73LPS vaccine
#74Newcastle disease virus vectored avian vaccines
#75VACCINE DELIVERY METHOD
#76Oncolytic heterologous recombinant newcastle disease virus, preparation method and application thereof
#77Immunogenic composition
#78Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector
#79Chimeric viruses presenting non-native surface proteins and uses thereof
#80Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#81H5 PROTEINS OF H5N1 INFLUENZA VIRUS FOR USE AS A MEDICAMENT
#82EXTENDED-RANGE SPRAY APPLICATOR
#83Traditional chinese medicine mulberry leaves polysaccharide and eucommia polysaccharide immunostimulant and application thereof
#84ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#85Method of making a virus using duck embryonic derived stem cell lines
#86Reduced foaming vaccine compositions
#87Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#88Recombinant Marek's disease viruses and uses thereof
#89Acceleration of vector virus induced immune response in avians
#90Chimeric newcastle disease viruses and uses thereof
#91COMPOSITIONS, VECTORS, KITS, AND METHODS FOR IMMUNIZING AGAINST AVIAN INFECTIOUS BRONCHITIS VIRUS
#92Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
#93Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
#94Induction of tumor immunity by variants of folate binding protein
#95Newcastle disease virus vectored herpesvirus vaccines
#96Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#97LPS vaccine
#98Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#99Recombinant nonpathogenic MDV vector providing multivalent immunity
#100Newcastle disease virus vectored avian vaccines
#101Immunostimulatory oligodeoxynucleotides
#102Recombinant vaccine against PRRS in a viral vector
#103INFLUENZA H5 VACCINES
#104Method of vaccination comprising a histone deacetylase inhibitor
#105Emulsion containing a non-live medicinal substance
#106Generation of duck cell lines
#107Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#108COMPOSITIONS, VECTORS, KITS, AND METHODS FOR IMMUNIZING AGAINST AVIAN INFECTIOUS BRONCHITIS VIRUS
#109Chimeric Newcastle disease viruses and uses thereof
#110Newcastle disease virus and the use thereof as a vaccine
#111Induction of tumor immunity by variants of folate binding protein
#112USE OF NEWCASTLE DISEASE VIRUS-BASED VECTOR FOR INDUCING AN IMMUNE RESPONSE IN MAMMALS
#113Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#114INACTIVATED POULTRY VACCINE
#115Vaccine
#116Chimeric viruses presenting non-native surface proteins and uses thereof
#117Sticky soft gel for treating poultry
#118Chimeric Newcastle disease viruses and uses thereof
#119Newcastle disease virus vectored herpesvirus vaccines
#120Recombinant NDV antigen and uses thereof
#121INACTIVATED VIRUS COMPOSITIONS AND METHODS OF PREPARING SUCH COMPOSITIONS
#122Virus-like particles as vaccines for paramyxovirus
#123Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof
#124Newcastle disease virus vectored avian vaccines
#125NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#126Attenuated recombinant newcastle disease virus and vaccine containing the same
#127ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#128METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY
#129METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY
#130DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE PRODUCTION OF VIRAL VACCINES
#131Novel Vaccination Carrier
#132Preparation of vaccine master cell lines using recombinant plant suspension cultures
#133Virus-like particles as vaccines for paramyxovirus
#134AVIAN VIRUS VACCINES AND USES THEREOF
#135Induction of tumor immunity by variants of folate binding protein
#136Methods for the propagation of modified influenza viruses in embryonated eggs
#137Virus-like particles as vaccines for paramyxovirus
#138Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#139Methods and compositions for vaccination of poultry
#140Methods and compositions for vaccination of poultry
#141Virus-like particles as vaccines for paramyxovirus
#142Preparation of vaccine master cell lines using recombinant plant suspension cultures
#143Stabilizers for veterinary vaccines
#144Vaccines
#145Methods of treating and detecting cancer using viruses
#146Escape mutants of newcastle disease virus as marker vaccines
#147Methods and interferon deficient substrates for the propagation of viruses